Parenteral
Drug Delivery |
|
| - |
Controlled duration of
drug delivery |
| - |
Controlled rate of drug delivery |
| - |
Complete bioerosion |
| - |
Simple/flexible fabrication |
|
Oral
Drug Delivery |
|
| - |
Site-specific drug delivery |
| - |
Reliable, sustained drug delivery |
|
| Topical |
Commercial
Products |
| - |
Approved products |
| - |
Adaptable to a wide variety of substances |
|
|
Parenteral
Sharex Laboratories is focused primarily on the development of its bioerodible
polymers for parenteral drug delivery, both injectable and implantable.
The Company has made substantial progress in developing these technologies,
opening up prospects for significant improvements over existing
approaches to drug delivery.
Oral
|
 |
